Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 17 studies | 29% ± 8% | |
| lung | 16 studies | 28% ± 11% | |
| brain | 12 studies | 28% ± 10% | |
| kidney | 8 studies | 21% ± 4% | |
| intestine | 8 studies | 25% ± 9% | |
| eye | 8 studies | 27% ± 10% | |
| liver | 7 studies | 32% ± 14% | |
| bone marrow | 5 studies | 21% ± 2% | |
| lymph node | 5 studies | 28% ± 7% | |
| uterus | 4 studies | 35% ± 13% | |
| breast | 4 studies | 25% ± 6% | |
| pancreas | 3 studies | 31% ± 9% | |
| placenta | 3 studies | 20% ± 4% | |
| thymus | 3 studies | 34% ± 12% | |
| adipose | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3600.67 | 1445 / 1445 | 100% | 47.66 | 183 / 183 |
| intestine | 100% | 3886.41 | 966 / 966 | 100% | 47.39 | 527 / 527 |
| lung | 100% | 3506.56 | 578 / 578 | 100% | 45.72 | 1155 / 1155 |
| ovary | 100% | 3949.62 | 180 / 180 | 100% | 28.49 | 430 / 430 |
| breast | 100% | 4161.81 | 459 / 459 | 100% | 43.20 | 1117 / 1118 |
| stomach | 100% | 2893.35 | 359 / 359 | 100% | 43.70 | 285 / 286 |
| brain | 100% | 2120.66 | 2632 / 2642 | 100% | 35.18 | 705 / 705 |
| bladder | 100% | 3957.52 | 21 / 21 | 100% | 36.85 | 502 / 504 |
| prostate | 100% | 2971.69 | 245 / 245 | 100% | 27.29 | 500 / 502 |
| uterus | 100% | 4124.91 | 170 / 170 | 99% | 37.59 | 456 / 459 |
| thymus | 100% | 3721.21 | 653 / 653 | 99% | 31.40 | 599 / 605 |
| pancreas | 100% | 2257.47 | 328 / 328 | 99% | 29.71 | 176 / 178 |
| kidney | 100% | 2426.67 | 89 / 89 | 98% | 30.88 | 885 / 901 |
| skin | 100% | 4476.20 | 1809 / 1809 | 98% | 39.24 | 461 / 472 |
| liver | 100% | 2015.07 | 226 / 226 | 96% | 19.36 | 388 / 406 |
| adrenal gland | 100% | 2754.69 | 258 / 258 | 93% | 16.68 | 214 / 230 |
| adipose | 100% | 4250.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 4203.76 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 37.86 | 29 / 29 |
| spleen | 100% | 3786.01 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 36.79 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.00 | 1 / 1 |
| muscle | 100% | 2022.93 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 1972.60 | 839 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 17.33 | 73 / 80 |
| peripheral blood | 83% | 3057.81 | 770 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000463 | Biological process | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005694 | Cellular component | chromosome |
| GO_0016020 | Cellular component | membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0003724 | Molecular function | RNA helicase activity |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | DDX18 |
| Protein name | ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb) ATP-dependent RNA helicase (EC 3.6.4.13) Uncharacterized protein DDX18 |
| Synonyms | cPERP-D |
| Description | FUNCTION: Probable RNA-dependent helicase. FUNCTION: RNA helicase. . FUNCTION: RNA helicase. . |
| Accessions | H7C452 Q4ZG72 Q9NVP1 ENST00000263239.7 Q53TI6 ENST00000415038.1 |